Massed cognitive processing therapy for combat-related posttraumatic stress disorder: Study design and methodology of a non-inferiority randomized controlled trial
Contemporary Clinical Trials · 2024
DOI: 10.1016/j.cct.2023.107405 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Contemporary Clinical Trials, 2024. Verfasst von Jennifer Schuster Wachen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Women's Health Sciences Division, National Center for PTSD, VA Boston Healthcare System, 150 South Huntington Ave. (116B-3), Boston, MA 02130, USA; D…. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Combat Disorders, Military Personnel, Organothiophosphorus Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Congressionally Directed Medical Research Programs, Medical Research and Materiel Command, U.S. Department of Defense.
Abstract (Originalsprache)
BACKGROUND: Posttraumatic stress disorder (PTSD) is prevalent among military personnel. Cognitive processing therapy (CPT) is identified as one of the most effective treatments for PTSD, although smaller effects have been found in military populations. High rates of dropout from treatment may contribute to reduced efficacy, and military personnel may face unique barriers to treatment completion. One method of improving efficacy may be to reduce dropout by decreasing the time required to receive a full dose of treatment. This paper describes the design and methodology of the first randomized clinical trial testing whether CPT delivered in an intensive format is non-inferior to standard delivery of CPT. METHOD: Participants are 140 active duty service members randomized to receive CPT in a 5-day combined group and individual intensive outpatient format (MCPT) or standard CPT (delivered individually twice weekly over 6 weeks). Participants are assessed at baseline, and 1 month, 4 months, and 1 year following the conclusion of the therapy. Reduction in PTSD symptomatology is the primary outcome of interest. Secondary outcomes include comorbid psychological symptoms, health, and functioning. A secondary objective is to examine predictors of treatment outcome to determine which service members benefit most from which treatment modality. CONCLUSION: If determined to be non-inferior, MCPT would provide an efficient and accessible modality of evidence-based PTSD treatment. This therapy format would improve access to care by reducing the amount of time required for treatment and improving symptoms and functioning more rapidly, thereby minimizing interference with work-related activities and disruption to the mission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Women's Health Sciences Division, National Center for PTSD, VA Boston Healthcare System, 150 South Huntington Ave. (116B-3), Boston, MA 02130, USA; Department of Psychiatry, Boston University Chobanian & Avedisian Schoo…
- Alexander T. Augusta Military Medical Center, 9300 DeWitt Loop, Fort Belvoir, VA 22060, USA.
- Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3901, USA.
- Department of Psychiatry and Behavioral Sciences, Duke University, 2400 Pratt St., Durham, NC 27710, USA.
Förderung
- Congressionally Directed Medical Research Programs
- Medical Research and Materiel Command
- U.S. Department of Defense
Zitieren
APA
Wachen, J. S., Morris, K. L., Galovski, T. E., Dondanville, K. A., Resick, P. A., & Schwartz, C. (2024). Massed cognitive processing therapy for combat-related posttraumatic stress disorder: Study design and methodology of a non-inferiority randomized controlled trial. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107405
Vancouver
Wachen JS, Morris KL, Galovski TE, Dondanville KA, Resick PA, Schwartz C. Massed cognitive processing therapy for combat-related posttraumatic stress disorder: Study design and methodology of a non-inferiority randomized controlled trial. Contemporary Clinical Trials. 2024. doi:10.1016/j.cct.2023.107405
BibTeX
@article{Wachen2024,
author = {Wachen, Jennifer Schuster and Morris, Kris L and Galovski, Tara E and Dondanville, Katherine A and Resick, Patricia A and Schwartz, Carey},
title = {Massed cognitive processing therapy for combat-related posttraumatic stress disorder: Study design and methodology of a non-inferiority randomized controlled trial},
journal = {Contemporary Clinical Trials},
year = {2024},
doi = {10.1016/j.cct.2023.107405}
}
EUVIMED